Funder: Pershing Square Philanthropies
Due Dates (Anticipated): October 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 annually)
Summary: Supports early-career independent scientists pursuing innovative, high-risk, high-reward cancer research addressing important gaps or unmet needs.
Key Information: Applicants must have two to six years of independent laboratory leadership by the prize start date.
Description
The Pershing Square Sohn Cancer Prize, administered by the Pershing Square Sohn Cancer Research Alliance (PSSCRA), gives early-career scientists freedom to pursue bold research when traditional funding may be lacking. The program supports radically innovative, scientifically sound cancer research, including basic research and technological applications, with potential to advance understanding, diagnosis, prevention, or treatment.
Proposals should pose a clear biological question, offer a strong scientific rationale, and explain how the work could address an important gap or unmet need. The prize supports single-investigator projects while encouraging collaboration across institutions. Beyond funding, PSSCRA connects researchers with scientific collaborators, industry mentors, and investors to accelerate discoveries and collaboration between science and business.
